同种异体
老化
疾病
稳健性(进化)
有机体
长寿
生物
神经科学
生物信息学
医学
老年学
病理
遗传学
基因
作者
Philippe Kémoun,Isabelle Ader,Valérie Planat‐Benard,Cédric Dray,Nicolas Fazilleau,Paul Monsarrat,B. Cousin,J. Paupert,Marielle Ousset,Anne Lorsignol,Isabelle Raymond‐Letron,Bruno Vellas,Philippe Valet,Thomas B. L. Kirkwood,John Beard,Luc Pénicaud,Louis Casteilla
标识
DOI:10.1016/j.arr.2021.101537
摘要
Improvements in public health and health care have resulted in significant increases in lifespan globally, but also in a significant increase in chronic disease prevalence. This has led to a focus on healthy ageing bringing a shift from a pathology-centered to an intrinsic capacity and function-centered view. In parallel, the emerging field of geroscience has promoted the exploration of the biomolecular drivers of ageing towards a transverse vision by proposing an integrated set of molecular hallmarks. In this review, we propose to take a step further in this direction, highlighting a gerophysiological perspective that considers the notion of homeostasis/allostasis relating to robustness/fragility respectively. While robustness is associated with homeostasis achieved by an optimal structure/function relationship in all organs, successive repair processes occurring after daily injuries and infections result in accumulation of scar healing leading to progressive tissue degeneration, allostasis and frailty. Considering biological ageing as the accumulation of scarring at the level of the whole organism emphasizes three transverse and shared elements in the body - mesenchymal stroma cells/immunity/metabolism (SIM). This SIM tryptich drives tissue and organ fate to regulate the age-related evolution of body functions. It provides the basis of a gerophysiology perspective, possibly representing a better way to decipher healthy ageing, not only by defining a composite biomarker(s) but also by developing new preventive/curative strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI